Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy. Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society

Abstract

With approval of the AAN, ILAE, and authors, Epilepsia reproduced the article from Neurology summarizing practice guidelines for AEDs (Neurology 2004;62:1261–1273 and Epilepsia 2004;45:410–423). Unfortunately, on page 414 of the Epilepsia article (corresponding to page 1265 of the Neurology article) the abbreviation for the drug tiagabine (TGB) was omitted from a list of recommended effective drugs. This was due in its entirety to a typographical error in transposing drug names to abbreviated drug names. Epilepsia apologizes for the omission.